These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36480115)

  • 1. Increased HLA class II risk is associated with a more aggressive presentation of clinical type 1 diabetes.
    Kieleväinen V; Turtinen M; Luopajärvi K; Härkönen T; Ilonen J; Knip M;
    Acta Paediatr; 2023 Mar; 112(3):522-528. PubMed ID: 36480115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of familial type 1 diabetes: effects of the relationship to the affected family member on phenotype and genotype at diagnosis.
    Turtinen M; Härkönen T; Parkkola A; Ilonen J; Knip M;
    Diabetologia; 2019 Nov; 62(11):2025-2039. PubMed ID: 31346657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in the presentation of clinical type 1 diabetes defined by the level of risk conferred by human leukocyte antigen class II genotypes.
    Taka AM; Härkönen T; Vähäsalo P; Lempainen J; Veijola R; Ilonen J; Knip M;
    Pediatr Diabetes; 2022 Mar; 23(2):219-227. PubMed ID: 34894365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity.
    Ilonen J; Kiviniemi M; Lempainen J; Simell O; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2016 Jul; 17 Suppl 22():8-16. PubMed ID: 27411431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family history of type 2 diabetes and characteristics of children with newly diagnosed type 1 diabetes.
    Parkkola A; Turtinen M; Härkönen T; Ilonen J; Knip M;
    Diabetologia; 2021 Mar; 64(3):581-590. PubMed ID: 33331974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family history of diabetes and distribution of class II HLA genotypes in children with newly diagnosed type 1 diabetes: effect on diabetic ketoacidosis.
    Hekkala A; Ilonen J; Knip M; Veijola R;
    Eur J Endocrinol; 2011 Nov; 165(5):813-7. PubMed ID: 21890652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Pattern of First-Phase Insulin Response Is Associated With Genetic Variants Outside the Class II HLA Region in Children With Multiple Autoantibodies.
    Koskinen MK; Mikk ML; Laine AP; Lempainen J; Löyttyniemi E; Vähäsalo P; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Veijola R; Ilonen J; Toppari J
    Diabetes; 2020 Jan; 69(1):12-19. PubMed ID: 31591105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended family history of type 1 diabetes and phenotype and genotype of newly diagnosed children.
    Parkkola A; Härkönen T; Ryhänen SJ; Ilonen J; Knip M;
    Diabetes Care; 2013 Feb; 36(2):348-54. PubMed ID: 23033245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
    Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
    Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes.
    Salonen KM; Ryhänen S; Härkönen T; Ilonen J; Knip M;
    Diabetes Metab Res Rev; 2013 Nov; 29(8):646-54. PubMed ID: 23861236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.
    Alves LI; Davini E; Correia MR; Fukui RT; Santos RF; Cunha MR; Rocha DM; Volpini WM; Silva ME
    J Clin Immunol; 2012 Aug; 32(4):778-85. PubMed ID: 22402866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in Sweden.
    Carlsson A; Kockum I; Lindblad B; Engleson L; Nilsson A; Forsander G; Karlsson AK; Kernell A; Ludvigsson J; Marcus C; Zachrisson I; Ivarsson SA; Lernmark A;
    Int J Obes (Lond); 2012 May; 36(5):718-24. PubMed ID: 21712811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos.
    Bugawan TL; Klitz W; Alejandrino M; Ching J; Panelo A; Solfelix CM; Petrone A; Buzzetti R; Pozzilli P; Erlich HA
    Tissue Antigens; 2002 Jun; 59(6):452-69. PubMed ID: 12445315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of the HLA-A*24:02, B*39:01 and B*39:06 alleles with type 1 diabetes is restricted to specific HLA-DR/DQ haplotypes in Finns.
    Mikk ML; Heikkinen T; El-Amir MI; Kiviniemi M; Laine AP; Härkönen T; Veijola R; Toppari J; Knip M; Ilonen J;
    HLA; 2017 Apr; 89(4):215-224. PubMed ID: 28185422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct.
    Howson JM; Stevens H; Smyth DJ; Walker NM; Chandler KA; Bingley PJ; Todd JA
    Diabetes; 2011 Oct; 60(10):2635-44. PubMed ID: 21831970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended family history of type 1 diabetes in HLA-predisposed children with and without islet autoantibodies.
    Kuusela S; Keskinen P; Pokka T; Knip M; Ilonen J; Vähäsalo P; Veijola R
    Pediatr Diabetes; 2020 Dec; 21(8):1447-1456. PubMed ID: 32939969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk. Belgian Diabetes Registry.
    van der Auwera B; Schuit F; Lyaruu I; Falorni A; Svanholm S; Vandewalle CL; Gorus FK
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2567-73. PubMed ID: 7673396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity.
    Walter M; Albert E; Conrad M; Keller E; Hummel M; Ferber K; Barratt BJ; Todd JA; Ziegler AG; Bonifacio E
    Diabetologia; 2003 May; 46(5):712-20. PubMed ID: 12750767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.